Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acid-Catalyzed Aldol Addition Reaction01:15

Acid-Catalyzed Aldol Addition Reaction

The aldol reaction of a ketone under acidic conditions successfully forms an unsaturated carbonyl as the final product instead of an aldol. The acid-catalyzed aldol reaction is depicted in Figure 1.
Base-Catalyzed Aldol Addition Reaction01:08

Base-Catalyzed Aldol Addition Reaction

As depicted in Figure 1, base-catalyzed aldol addition involves adding two carbonyl compounds in aqueous sodium hydroxide to form a β-hydroxy carbonyl compound.
Crossed Aldol Reaction Using Strong Bases: Directed Aldol Reaction00:56

Crossed Aldol Reaction Using Strong Bases: Directed Aldol Reaction

The reaction between two different carbonyl compounds comprising α hydrogen in the presence of a strong base like lithium diisopropylamide (LDA) to form a crossed aldol product is known as a directed aldol reaction. The directed aldol reaction is depicted in Figure 1.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expanding roles of cGAS-STING signaling in neuroinflammation.

The Journal of clinical investigation·2026
Same author

AI guided discovery of a murine model of asymptomatic Alzheimer's disease.

Acta neuropathologica communications·2026
Same author

cGAS inhibition delays TDP-43-driven ALS Pathogenesis.

bioRxiv : the preprint server for biology·2026
Same author

cGAS-mediated IFN-I signaling contributes to disease progression in drug-refractory epilepsy.

bioRxiv : the preprint server for biology·2026
Same author

Total Synthesis of Okeaniamide A.

Organic letters·2026
Same author

High-Throughput Screening and Initial SAR Studies Identify a Novel Submicromolar Potent Human cGAS Inhibitor.

ACS chemical biology·2025

Related Experiment Video

Updated: Jun 23, 2026

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

Multiple catalytic aldolase antibodies suitable for chemical programming.

Rajib Kumar Goswami1, Zheng-Zheng Huang, Jane S Forsyth

  • 1The Skaggs Institute for Chemical Biology, Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Bioorganic & Medicinal Chemistry Letters
|May 12, 2009
PubMed
Summary

Researchers chemically programmed murine antibodies with aldolase activity using diketone or pro-vinyl ketone linkers. Three new antibodies (84G3, 85H6, 90G8) showed specific binding to human tumor cells expressing integrin alpha(v)beta(3.).

More Related Videos

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
09:06

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition

Published on: December 23, 2016

Related Experiment Videos

Last Updated: Jun 23, 2026

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
09:06

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition

Published on: December 23, 2016

Area of Science:

  • Chemical Biology
  • Immunology
  • Biochemistry

Background:

  • Catalytic antibodies offer precise chemical reaction control.
  • Integrin adhesion receptors are crucial in tumor cell interactions.
  • Chemical programming enables tailored antibody functionalities.

Purpose of the Study:

  • To investigate chemical programming of murine antibodies with aldolase activity.
  • To evaluate the efficacy of diketone and pro-vinyl ketone linkers for antibody functionalization.
  • To develop novel antibodies targeting tumor-associated integrins.

Main Methods:

  • Utilized nine murine antibodies with inherent catalytic aldolase activity.
  • Employed diketone and pro-vinyl ketone linkers for antibody programming.
  • Assessed antibody binding specificity to human tumor cells expressing integrin alpha(v)beta(3.).

Main Results:

  • Most antibodies were successfully programmed using diketone linkers, mirroring previous methods.
  • Efficient catalysis of the retro aldol reaction by antibodies was crucial for pro-vinyl ketone linker programming.
  • Three newly developed antibodies (84G3, 85H6, 90G8) demonstrated high specific binding to target tumor cells.

Conclusions:

  • Chemical programming is effective for creating functional catalytic antibodies.
  • Linker chemistry influences the success of antibody programming and activity.
  • Engineered antibodies show promise for targeted cancer therapies by targeting integrin alpha(v)beta(3.).